KÖK HÜCRE NAKLİ UYGULANAN COVİD-19 TANILI YOĞUN BAKIM HASTASININ HEMŞİRELİK BAKIMI: OLGU SUNUMU

Year 2021, Volume: 25 Issue: 2, 108 - 120, 28.08.2021

Didem Cengiz Hamdiye Banu Katran , Ali Akgün

Abstract

Dünya Sağlık Örgütü (DSÖ) tarafından 11 Mart 2020 tarihinde küresel salgın olarak ilan edilen koronavirüs hastalığı (Covid-19), ilk olarak Çin’in Hubei Eyaleti’nde ortaya çıkmış ve buradan tüm dünyaya yayılmıştır. Covid-19 hastalarda ciddi solunum yetmezliği tablosu oluşturmakta bu nedenle birçok hasta yoğun bakım ünitelerinde solunum desteğine ihtiyaç duymaktadır. Ülkemizde de salgının başlangıcından bu yana yoğun bakım üniteleri çok sayıda hastaya hizmet vermiştir. Yoğun bakım ünitelerinde hasta bakım ve tedavisinde görev alan yoğun bakım hemşirelerine kritik durumdaki Covid-19 hastalarının bakımı ve tedavisinde ciddi sorumluluklar düşmektedir. Bu olgu analizinde 46 yaşında, Covid-19 tanısı almış ve yoğun bakımda kök hücre nakli uygulanan hasta ve hemşirelik girişimleri sunulmuştur.

Keywords

covid-19, Kök Hücre Nakli, Yoğun Bakım Ünitesi, Hemşirelik Bakımı

Supporting Institution

-

Project Number

-

NURSING CARE OF A COVID-19 INTENSIVE CARE PATIENT WITH STEM CELL TRANSPLANTATION: CASE REPORT

Abstract

The coronavirus disease (Covid-19), declared as a global pandemic by the World Health Organization (WHO) on March 11, 2020, first appeared in Hubei Province of China and spread from there to the whole world. Covid-19 causes severe respiratory failure in patients, so many patients need respiratory support in intensive care units. Intensive care units have served many patients in our country since the beginning of the epidemic. Intensive care nurses, who work in the care and treatment of patients in intensive care units, have serious responsibilities in the care and treatment of critically ill Covid-19 patients. In this case analysis, a 46-year-old patient with a diagnosis of Covid-19 and a stem cell transplant in intensive care unit and nursing interventions are presented.

Keywords

covid-19, Stem Cell Transplant, Intensive care unit, nursing care

Project Number

-

References

• 1. Xiang YT, Yang Y, Li W, Zhang L, Zhang Q, Cheung T, & Ng CH. Timely mental health care for the 2019 novel coronavirus outbreak is urgently needed. The Lancet Psychiatry,2020;7(3): 228-9.
• 2.Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y,...Feng Z. Early transmission dynamics in Wuhan, China, of novel coronavirus–infected pneumonia. N Engl J Med. 2020; 382:1199-1207.
• 3.Lee PI, Hsueh PR. Emerging threats from zoonotic coronaviruses-from SARS and MERS to 2019- nCoV. J Microbiol Immunol Infect. 2020;53(3):365-7.
• 3.Qin H, Zhao A. Mesenchymal stemcell therapy for acute respiratory distress syndrome: from basic to clinics. Protein&Cell. 2020;11(10):707–22.
• 4.Keating A. Mesenchymal stromal cells: new directions. Cell Stem Cell. 2012;10(6):709–16.
• 5.Golchin A, Farahany TZ, Khojasteh A, Soleimanifar F, & Ardeshirylajimi, A. The clinical trials of Mesenchymal stem cell therapy in skin diseases: An update and concise review. Current Stem Cell Research & Therapy. 2018;14(1), 22–33.
• 6. Zhu H, Xiong Y, Xia Y, Zhang R, Tian D, Wang T, ... & Zou L. Therapeutic effects of human umbilical cord derived mesenchymal stem cells in acute lung injury mice. Sci Rep. 2017;7(1):1-11
• 7. Lee DK, Song SU. Immunomodulatory mechanisms of mesenchymal stem cells and their the rapeutic applications. Cell Immunol. 2018;326:68–76.
• 8. Jiang W, Xu J. Immune modulation by mesenchymal stem cells. Cell Prolif. 2020;53(1):e12712.
• 9. Mehta P, Mcauley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ. Correspondence. Covid-19: consider cytokine storm syndromes and. The Lancet. 2020;6736(20):19–20.
• 10. Aggarwal S, Pittenger MF. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood. 2005;105(4):1815–22.
• 11. Krasnodembskaya A, Song Y, Fang X, Gupta N, Serikov V, Lee JW& Matthay MA. Antibacterial effect of human mesenchymal stem cells is mediated in part from secretion of the antimicrobial peptide LL-37. Stem Cells. 2010;28(12):2229–38.
• 12. Fu X, Liu G, Halim A, Ju Y, Luo Q, & Song G. Mesenchymal stemcell migration and tissue repair. Cells. 2019; 8(8):784.
• 13. Lee RH, Pulin AA, Seo MJ, Kota DJ, Ylostalo J, Larson BL,... & Prockop DJ. Intravenoush MSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6. Cell Stem Cell. 2009;5(1):54–63.
• 14. Carpenito-Moyet JL. Hemşirelik tanıları el kitabı. Erdemir F (Çeviri Editörü), Türkçeleştirilmiş İkinci Baskı. İstanbul: Nobel Tıp Kitabevleri; 2005
• 15. North American Nursing Diagnosis Association- NANDA. The 3. Complete list of NANDA Nursing Diagnosis for 2012-2014, with 16 new diagnoses. http://www.kc-courses.com/fundamentals/week2process/nan- da2012.pdf. January 15, 2015.
• 16. Karasu F, Çopur EÖ. Covid-19 vakaları artarken salgının ön safındaki bir yoğun bakım hemşiresi: “Cephede Duran Kahramanlar”. Yoğun Bakım Hemşireliği Dergisi 2020;24(1):11.
• 17. Kaya N. NANDA Hemşirelik Tanıları, Hemşirelik Bakımın Sonuçları (NOC) ve Hemşirelik Girişimleri (NIC) Sınıflama Sistemlerinin İlişkilendirilmesi. İstanbul Üniversitesi F.N.H.Y.O. Dergisi, 2004, 13(52):121-130.
• 18. Bulechek GM, Butcher HK, Dochterman JM, Wagner C. Nursing Interventions Classification (NIC) [Hemşirelik Girişimleri Sınıflaması (NIC)]. Erdemir F, Kav S, Akman Yılmaz A, translator. İstanbul: Nobel Tıp Kitabevleri / in collaboration with Elsevier; 2017.
• 19. Herdman TH, Kamitsuru S. NANDA International Nursing Diagnoses Definitions and Classification 2015-17. 10th ed. Oxford: WILEY Blackwell; 2014